Skip to main content
. 2019 Feb 15;9(2):e024854. doi: 10.1136/bmjopen-2018-024854

Table 5.

Discrimination across clinical severity groups

CKD stage EQ-5D-3L SF-6D
N Mean (SD) Median Sig* ES N Mean (SD) Median Sig* ES
Early stage 254 (24.0) 0.588 (0.30) 0.656 <0.001 254 (24.0) 0.551 (0.10) 0.570 <0.001
IV 614 (58.1) 0.566 (0.42) 0.620 0.071 614 (58.1) 0.536 (0.09) 0.560 0.141
V 151 (14.3) 0.467 (0.42) 0.585 0.305 151 (14.3) 0.523 (0.08) 0.550 0.138
Dialysis 38 (3.6) 0.126 (0.39) −0.016 0.807 38 (3.6) 0.432 (0.07) 0.410 1.098

*Kruskal-Wallis test.

CKD, chronic kidney disease; EQ-5D-3L, EuroQoL-five-dimension-3 levels; ES, effect size; SF-6D, Short-Form six-dimension.